| Literature DB >> 26205057 |
Xin Liu1, Junsheng Zhang2, Qiao Liu3, Guihua Tang4, Hongsheng Wang5, Chengqi Fan6, Sheng Yin7.
Abstract
Four new cembranoids, sarcophelegans A-D (1-4) and six known analogues (5-10) were isolated from the South China Sea soft coral Sarcophyton elegans. Their structures were elucidated through detailed spectroscopic analysis, and the absolute configuration of 1 was confirmed by single-crystal X-ray diffraction. The antimigratory potential of compounds 1-10 were evaluated and compounds 2 and 6 were found to inhibit human breast tumor MDA-MB-231 cell migration at 10 μM.Entities:
Keywords: Sarcophyton elegans; antimigratory activity; cembranoids
Mesh:
Substances:
Year: 2015 PMID: 26205057 PMCID: PMC6331945 DOI: 10.3390/molecules200713324
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Compounds 1–10 isolated from Sarcophyton elegans.
1H-NMR spectroscopic data of 1–4 (400 MHz, J in Hz, δ in ppm).
| Position | 1 a | 2 a | 3 a | 4 b |
|---|---|---|---|---|
| 2 | 5.69, d (11.3) | 5.55, d (16.7) | 5.54, d (16.3) | 6.23 d (11.4) |
| 3 | 2.35, m (overlapped) | 5.69, d (16.7) | 5.74, d (16.3) | 6.72, brd (11.4) |
| 5a | 1.98, m | 1.77, m (overlapped) | 1.83, m (overlapped) | |
| 5b | 1.87, m | 1.55, ddd (14.2, 10.5, 7.4) | 1.46, m | |
| 6a | 2.21, m | 3.04, ddd (20.9, 10.5, 7.4) | 1.70, m | 4.90, d (16.8) |
| 6b | 1.90, m | 2.44, m (overlapped) | 1.38, m | 3.29, d (16.8) |
| 7 | 3.25, brd (11.0, 1.4) | |||
| 9a | 2.82, dd (14.4, 14.4) | 1.96, m | 1.88, m | 2.40, m (overlapped) |
| 9b | 1.73, dd (14.4, 7.6) | 1.77, m (overlapped) | 1.79, m | 2.01, m |
| 10a | 2.31, m | 3.40, m | 3.44, m | 2.73, m |
| 10b | 1.38, m | 2.17, m | 2.05, m | 2.31, m |
| 11 | 3.13, dd (7.0, 7.0) | 5.67, m | 6.19, dd (10.1, 5.1) | 6.10, dd (4.1, 4.1) |
| 13a | 2.62, m | 2.45, m (overlapped) | 2.60, m | 3.19, m |
| 13b | 1.30, m | 2.55, m | 1.92, m | |
| 14a | 2.51, m | 2.12, m | 2.16, m | 2.56, dd (13.8, 13.8) |
| 14b | 2.12, m | 1.76 m | 1.84, m (overlapped) | 2.23, dd (13.8, 7.8) |
| 15 | 2.34, m (overlapped) | 1.86, m | 1.87, m | 2.41, m (overlapped) |
| 16 | 1.19, d (6.9) | 0.98, d (6.8) | 0.98, d (7.1) | 1.07, d (6.8) |
| 17 | 1.09, d (6.9) | 0.95, d (6.8) | 0.96, d (7.1) | 1.09, d (6.8) |
| 18 | 1.10, s | 1.39, s | 1.33, s | 1.83, s |
| 19 | 1.34, s | 1.21, s | 1.15, s | 1.54, s |
a Measured in CD3OD; b Measured in CDCl3.
13C-NMR spectroscopic data of 1–4 (100 MHz, δ in ppm).
| Position | 1 a | 2 a | 3 a | 4 b |
|---|---|---|---|---|
| 1 | 147.1, C | 87.8, C | 88.0, C | 158.8, C |
| 2 | 120.1, CH | 128.2, CH | 128.3, CH | 119.4, CH |
| 3 | 52.0, CH | 140.4, CH | 140.8, CH | 137.8, CH |
| 4 | 83.4, C | 72.8, C | 73.4, C | 133.3, C |
| 5 | 38.5, CH2 | 36.5, CH2 | 41.0, CH2 | 195.1, C |
| 6 | 34.7, CH2 | 35.2, CH2 | 25.4, CH2 | 45.7, CH2 |
| 7 | 88.9, C | 219.3, C | 76.0, CH | 204.3, C |
| 8 | 91.9, C | 79.7, C | 75.8, C | 86.1, C |
| 9 | 29.9, CH2 | 42.0, CH2 | 39.0, CH2 | 33.3, CH2 |
| 10 | 24,1, CH2 | 25.9, CH2 | 25.5, CH2 | 27.2, CH2 |
| 11 | 65.6, CH | 150.3, CH | 149.5, CH | 143.6, CH |
| 12 | 60.4, C | 125.1, C | 125.5, C | 130.9, C |
| 13 | 33.0, CH2 | 25.0, CH2 | 25.8, CH2 | 37.1, CH2 |
| 14 | 25.8, CH2 | 27.5, CH2 | 27.5, CH2 | 27.6, CH2 |
| 15 | 34.0, CH | 38.4, CH | 38.9, CH | 36.3, CH |
| 16 | 21.3, CH3 | 17.4, CH3 | 17.4, CH3 | 22.4, CH3 |
| 17 | 23.9, CH3 | 17.1, CH3 | 17.1, CH3 | 21.7, CH3 |
| 18 | 26.2, CH3 | 29.3, CH3 | 30.2, CH3 | 10.9, CH3 |
| 19 | 25.1, CH3 | 28.5, CH3 | 24.4, CH3 | 28.9, CH3 |
| 20 | 173.9, C | 168.8, C | 169.5, C | 165.8, C |
a Measured in CD3OD; b Measured in CDCl3.
Figure 2Key 1H-1H COSY (▬) and HMBC () correlations for 1, 2, and 4.
Figure 3ORTEP depiction for X-ray crystal structures of 1.
Figure 4Selected NOESY correlations of 2 (↔).
Figure 5Wound-healing assays on compounds 1–10 with human breast tumor cell MDA-MB-231. (A) The antimigration effects of 1–10 at 10 μM on the tumor cells (* p < 0.05); (B) The incubation of 2 and 6 with tumor cells at 0, 12, 24, and 48 h (left: control; middle: 2 at 10 μM; right: 6 at 10 μM).